US DOT Proposes Adding 4 Opioids to Drug Testing Panel

The Department of Transportation is proposing to amend its drug-testing program regulation to add four opioids (hydrocodone, hydromorphone, oxymorphone, and oxycodone) to its testing panel.

U.S. DOT also proposes adding methylenedioxyamphetamine (MDA) as an initial test analyte and remove methylenedioxyethylamphetamine (MDEA) as a confirmatory test analyte.

Published in the Federal Register for Jan. 23, the notice of proposed rulemaking aims to align DOT’s regulated-industry drug testing with the Department of Health and Human Services’ laboratory drug-testing requirements.

(more on provisions in US DOT’s proposed rulemaking . . . )